DK0473564T3 - Antikoagulant kombination af LACI og sulfatiserede polysaccharider - Google Patents

Antikoagulant kombination af LACI og sulfatiserede polysaccharider

Info

Publication number
DK0473564T3
DK0473564T3 DK91870132.7T DK91870132T DK0473564T3 DK 0473564 T3 DK0473564 T3 DK 0473564T3 DK 91870132 T DK91870132 T DK 91870132T DK 0473564 T3 DK0473564 T3 DK 0473564T3
Authority
DK
Denmark
Prior art keywords
laci
sulfated polysaccharides
combination
anticoagulant
anticoagulant combination
Prior art date
Application number
DK91870132.7T
Other languages
English (en)
Inventor
Tze-Chein Wun
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of DK0473564T3 publication Critical patent/DK0473564T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91870132.7T 1990-08-27 1991-08-26 Antikoagulant kombination af LACI og sulfatiserede polysaccharider DK0473564T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57308390A 1990-08-27 1990-08-27

Publications (1)

Publication Number Publication Date
DK0473564T3 true DK0473564T3 (da) 1996-04-15

Family

ID=24290576

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91870132.7T DK0473564T3 (da) 1990-08-27 1991-08-26 Antikoagulant kombination af LACI og sulfatiserede polysaccharider

Country Status (10)

Country Link
EP (1) EP0473564B1 (da)
JP (1) JPH0733336B2 (da)
AT (1) ATE135585T1 (da)
CA (1) CA2049873C (da)
DE (1) DE69118056T2 (da)
DK (1) DK0473564T3 (da)
ES (1) ES2085462T3 (da)
GR (1) GR3020312T3 (da)
IE (1) IE913004A1 (da)
PT (1) PT98779B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
PT769962E (pt) * 1994-07-07 2003-07-31 Univ Washington Metodo de atenuacao da estenose arterial
EP0774001B1 (en) * 1994-08-05 2002-10-16 Chiron Corporation Production of tissue factor pathway inhibitor
US5589359A (en) 1994-08-05 1996-12-31 Chiron Corporation Chimeric proteins
AU759412B2 (en) * 1995-06-07 2003-04-17 G.D. Searle & Co. Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
EP0837883B1 (en) * 1995-06-07 2005-08-10 Chiron Corporation Method of solubilizing, purifying, and refolding protein
AU2003200506B2 (en) * 1995-06-07 2007-01-18 G.D. Searle Llc Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
AU1042597A (en) * 1995-12-18 1997-07-14 Stichting Sanquin Bloedvoorziening Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
IL161407A0 (en) 2001-10-15 2004-09-27 Chiron Corp Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
US7851433B2 (en) 2003-08-13 2010-12-14 Novartis Vaccines And Diagnostics, Inc. Method of purifying TFPI and TFPI analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington Method of isolating highly purified tissue factor inhibitor
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor
EP0439442B1 (en) * 1990-01-25 1996-03-06 Washington University Factor x-laci hybrid protein

Also Published As

Publication number Publication date
EP0473564B1 (en) 1996-03-20
DE69118056D1 (de) 1996-04-25
GR3020312T3 (en) 1996-09-30
PT98779B (pt) 1999-06-30
IE913004A1 (en) 1992-03-11
PT98779A (pt) 1992-07-31
JPH04257524A (ja) 1992-09-11
CA2049873C (en) 2001-12-04
EP0473564A1 (en) 1992-03-04
ES2085462T3 (es) 1996-06-01
JPH0733336B2 (ja) 1995-04-12
DE69118056T2 (de) 1996-10-24
CA2049873A1 (en) 1992-02-28
ATE135585T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
ES2085462T3 (es) Combinacion anticoagulante de laci y de polisacaridos sulfatados.
DK0605293T3 (da) Polymersammensætninger med lav gulningsgrad, polymeriserbare sammensætninger og deraf fremstillede linser
DK1284740T3 (da) Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser
DE69206111D1 (de) Herstellungsverfahren von Turbinen- oder Verdichtershaufeln.
DE69105713D1 (de) Prothetische femorale komponente.
DK0426221T3 (da) Optisk forstærkningsenhed med lav støj og refleksion af pumpeeffekten
ES2044152T3 (es) Protesis de correccion de rodilla.
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
DK1336605T3 (da) Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X
FI925101L (fi) Foerfarande foer framstaellning av mikrokapslar som innehaoller i ett matrismaterial inkapslat aromaemne och med foerfarandet framstaellda produkter
FI913294A0 (fi) Kraftkonverteringsmaskin med roterande kolvar i par relativt varandra i ett sfaeriskt hus.
FR2653992B1 (fr) Prothese totale du genou a glissement.
ES2167748T3 (es) Derivados del polisacarido k5 con actividad anticoagulante.
FI915152A7 (fi) HIV-käänteistranskriptaasi-inhibiittoreiden synergismi
FR2702651B1 (fr) Prothèse du genou.
ATE143810T1 (de) Hepatozytwachstumsfaktor enthaltende mittel
DK0393948T3 (da) Koncentreret vandig opløsning af glutaraldehyd og 1,2-benzisothiazolin-3-on
ATE92325T1 (de) Kombinationspraeparat mit antithrombotischer wirkung.
FR2710258B1 (fr) Prothèse du genou.
DK0443429T3 (da) Stabiliserede sulfonater og sulfater af hirudin
FR2670670B1 (fr) Instrument de chirurgie corneenne.
FR2672798B1 (fr) Prothese du genou.
FR2707871B1 (fr) Prothèse bicondylienne du genou du type à glissement.
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
FR2692140B1 (fr) Prothèse partielle unicompartimentaire de genou.